i-Ome Discovery protein array

16 May 2024

The i-Ome® Discovery platform from Sengenics offers a high-throughput functional protein array for precise autoantibody profiling, crucial for understanding disease mechanisms and advancing personalized diagnostic and therapeutic approaches in precision medicine. Utilizing KREX® technology for structural preservation of antigens and offering dual isotype detection, i-Ome Discovery enables comprehensive immune response profiling with reduced false discovery rates and smaller sample sizes, facilitating efficient biomarker discovery and clinical application. Sengenics highlights how i-Ome Discovery facilitates the precise identification of autoantibodies for actionable insights. With its expansive array of over 1800 human proteins, the i-Ome Discovery represents a significant advancement in the field of auto-antibody profiling for understanding disease initiation and progression.

i-Ome® Discovery Protein Array

SomaLogic

The i-Ome Discovery Protein Array uses the patented KREX® protein folding technology to enable accurate and reproducible profiling of patient samples against more than 1800 carefully selected full-length, properly folded proteins. Curated content focused on known and potential autoantigens helps facilitate biomarker discovery with significantly lower false discovery rates and smaller sample sizes than other technologies. The i-Ome Discovery Protein Array is ideal for Biomarker Discovery.

(0)

Links

Tags

i-Ome Discovery protein array